No Data
Hutchmed Divests 45% Interest in Shanghai Hutchison for $608M
Sector Update: Health Care Stocks Edge Higher Premarket Thursday
HUTCHMED Shares Are Trading Higher After the Company Announced the Divestment of Its 45% Interest in Shanghai Hutchison Pharmaceuticals.
Express News | HUTCHMED Shares Are Trading Higher After the Company Announced the Divestment of Its 45% Interest in Shanghai Hutchison Pharmaceuticals
Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million
6-K: Report of foreign private issuer (related to financial reporting)
